Mariner’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Buy |
15,594
+823
| +6% | +$85.9K | ﹤0.01% | 1471 |
|
|
2025
Q1 | $1.72M | Sell |
14,771
-349
| -2% | -$40.7K | ﹤0.01% | 1325 |
|
|
2024
Q4 | $1.28M | Buy |
15,120
+1,834
| +14% | +$155K | ﹤0.01% | 1485 |
|
|
2024
Q3 | $1.19M | Buy |
13,286
+10,149
| +324% | +$912K | ﹤0.01% | 1476 |
|
|
2024
Q2 | $253K | Buy |
3,137
+523
| +20% | +$42.1K | ﹤0.01% | 2588 |
|
|
2024
Q1 | $209K | Sell |
2,614
-115
| -4% | -$9.18K | ﹤0.01% | 2735 |
|
|
2023
Q4 | $217K | Buy |
+2,729
| New | +$217K | ﹤0.01% | 2626 |
|
|
2019
Q3 | – | Sell |
-23,025
| Closed | -$593K | – | 711 |
|
|
2019
Q2 | $593K | Buy |
23,025
+1,500
| +7% | +$38.6K | 0.01% | 671 |
|
|
2019
Q1 | $306K | Sell |
21,525
-20,000
| -48% | -$284K | ﹤0.01% | 807 |
|
|
2018
Q4 | $117K | Hold |
41,525
| – | – | ﹤0.01% | 802 |
|
|
2018
Q3 | $143K | Hold |
41,525
| – | – | ﹤0.01% | 780 |
|
|
2018
Q2 | $133K | Hold |
41,525
| – | – | ﹤0.01% | 762 |
|
|
2018
Q1 | $102K | Hold |
41,525
| – | – | ﹤0.01% | 617 |
|
|
2017
Q4 | $233K | Hold |
41,525
| – | – | 0.01% | 501 |
|
|
2017
Q3 | $230K | Hold |
41,525
| – | – | 0.01% | 455 |
|
|
2017
Q2 | $228K | Sell |
41,525
-4,475
| -10% | -$24.6K | 0.01% | 450 |
|
|
2017
Q1 | $179K | Buy |
46,000
+1,000
| +2% | +$3.89K | 0.01% | 555 |
|
|
2016
Q4 | $304K | Hold |
45,000
| – | – | 0.01% | 442 |
|
|
2016
Q3 | $355K | Buy |
45,000
+3,475
| +8% | +$27.4K | 0.02% | 432 |
|
|
2016
Q2 | $313K | Buy |
+41,525
| New | +$313K | 0.02% | 413 |
|